EGFR and neoplasm: Our xenograft data suggest that intratumoural injection of miR‐134 agomir decreased the expression of EGFR and suppressed tumour growth by inhibiting proliferation and inducing apoptosis of tumour cells, suggesting that miR‐134 could be a potential strategy for EGFR‐targeted therapy.